Cargando…
CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review)
In recent years, the incidence rate of breast cancer has increased year by year, and it has become a major threat to the health of women globally. Among all breast cancer subtypes, the hormone receptor (HR)(+)/human epidermal growth factor receptor 2 (HER2)(−) luminal subtype breast cancer is the mo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448295/ https://www.ncbi.nlm.nih.gov/pubmed/36043521 http://dx.doi.org/10.3892/ijmm.2022.5184 |